1984 Volume 32 Issue Supplement9 Pages 609-615
A new cephalosporin agent, AC-1370, was evaluated in the urological field and the following results were obtained.
AC-1370 was administered intravenously to 2 cases with acute simple pyelonephritis and 35 cases with acute and chronic complicated urinary tract infections.
AC-1370 was effective in 2 cases with acute simple pyelonephritis.
Effectiveness rate for 33 patients with acute and chronic complicated urinary tract infections was 55%. None of these patients recognized the side eect for AC-1370.
Slight transient elevation of laboratory findings in 3 cases (eosinophilia, GPT, GOT and GPT, respec-tively) were observed after the administration.